Lin Chen

Lin Chen

Auto-generated profile, based on publicly available information

Lin Chen

Division of Rheumatology, Inflammation, and Immunity, Brigham and Women’s Hospital and Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2024 in Nature
Verified
Journal Article
Closed access
PDF file
CLCalvin Law
Calvin Law
VWVanessa Sue Wacleche
Vanessa Sue Wacleche
YCYe Cao
Ye Cao
APArundhati Pillai
Arundhati Pillai
JSJohn Sowerby
John Sowerby
DRDeepak A. Rao
Deepak A. Rao

28 July 2023 in Science Immunology
Verified
Journal Article
Closed access
RWRunci Wang
Runci Wang
ASAnvita Singaraju
Anvita Singaraju
KMKathryne E. Marks
Kathryne E. Marks
LSLorien Shakib
Lorien Shakib
GDGarrett Dunlap
Garrett Dunlap
DRDeepak A. Rao
Deepak A. Rao
Immune checkpoint inhibitor (ICI) therapies used to treat cancer, such as anti–PD-1 antibodies, can induce autoimmune conditions in some individuals. The T cell mechanisms mediating such iatrogenic autoimmunity and their overlap with spontaneous autoimmune diseases remain unclear. Here, we compared T cells from the joints of 20 patients with an inflammatory arthritis induced by ICI therapy (ICI-arthritis) with two archetypal autoimmune arthritides, rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Single-cell transcriptomic and antigen receptor repertoire analyses highlighted clonal expansion of an activated effector CD8 T cell population in the joints and blood of patients with ICI-arthritis. These cells were identified as CD38 hi CD127 − CD8 T cells and were uniquely enriched in ICI-arthritis joints compared with RA and PsA and also displayed an elevated interferon signature. In vitro, type I interferon induced CD8 T cells to acquire the ICI-associated CD38 hi phenotype and enhanced cytotoxic function. In a cohort of patients with advanced melanoma, ICI therapy markedly expanded circulating CD38 hi CD127 − T cells, which were frequently bound by the therapeutic anti–PD-1 drug. In patients with ICI-arthritis, drug-bound CD8 T cells in circulation showed marked clonal overlap with drug-bound CD8 T cells from synovial fluid. These results suggest that ICI therapy directly targets CD8 T cells in patients who develop ICI-arthritis and induces an autoimmune pathology that is distinct from prototypical spontaneous autoimmune arthritides.

7 October 2022 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
TSTakanori Sasaki
Takanori Sasaki
SBSabrina Bracero
Sabrina Bracero
JKJoshua Keegan
Joshua Keegan
LCLin Chen
Lin Chen
YCYe Cao
Ye Cao
DRDeepak A. Rao
Deepak A. Rao

1 January 2022 in Phytomedicine
Verified
Journal Article
Closed access
XZXiang Zhou
Xiang Zhou
WWWei-Ming Wang
Wei-Ming Wang
ZLZhaofeng Li
Zhaofeng Li
LCLin Chen
Lin Chen
CWChunmei Wen
Chunmei Wen
JDJie Deng
Jie Deng

15 February 2022 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
Sara K. TedeschiSara K. Tedeschi
Sara K. Tedeschi
JSJacklyn Stratton
Jacklyn Stratton
JEJack Elias Ellrodt
Jack Elias Ellrodt
MWMary Grace Whelan
Mary Grace Whelan
KHKeigo Hayashi
Keigo Hayashi
DSDaniel H Solomon
Daniel H Solomon

26 July 2024 in Nature
Verified
Journal Article
Open access
PDF file
CLCalvin Law
Calvin Law
VWVanessa Sue Wacleche
Vanessa Sue Wacleche
YCYe Cao
Ye Cao
APArundhati Pillai
Arundhati Pillai
JSJohn Sowerby
John Sowerby
DRDeepak A. Rao
Deepak A. Rao